Former CMS Official Says Agency Lacks Authority, Funding To Match FDA Innovation

A former CMS official said the agency's efforts to reimburse innovative new treatments are being stifled by a lack of clear authority over evidence development and waning resources. Louis Jacques, senior vice president and chief clinical officer for ADVI, suggested CMS' parallel device review pilot with FDA might not be beneficial unless CMS is given staffing equivalent to FDA or the funding to develop the same level of expertise. The comments came as multiple industry stakeholders week warned the House...